Reconstruction
BIA-ALCL: the rare implant-associated lymphoma
BIA-ALCL is a rare cancer of the immune system that can develop in the scar capsule around a breast implant. It is not breast cancer. It is strongly associated with textured implants rather than smooth ones, and when found early it is usually treated successfully by removing the implant and the capsule.
The short answer
What is BIA-ALCL, and should I be worried?
It is a rare cancer of the immune system that can develop in the scar capsule around a breast implant. It is not breast cancer. It is strongly associated with textured implants rather than smooth ones, and when found early it is usually treated successfully by removing the implant and the capsule.
Why it is discussed at all, given how rare it is
Because the main symptom is easy to dismiss. A breast that swells suddenly, often years after an uneventful reconstruction, is the classic presentation, and women understandably assume it is a seroma and wait. Knowing to report it is the whole point.
Which implants carry the risk
Almost all reported cases have involved implants with a textured surface. Smooth implants carry a very low or negligible risk. Several highly textured types have been withdrawn in many countries for this reason.
What it is not
It is not a recurrence of your breast cancer, and it is not a reason to avoid reconstruction. It is a rare, recognised and largely treatable condition that your team already knows to look for.
Find out from your implant card whether yours are textured or smooth. That single fact answers most of the worry.Contact your breast team if a reconstructed breast swells noticeably over days or weeks, particularly if it happens more than a year after your operation. Also report a new lump in the breast or armpit, persistent pain, or a change in the skin over the implant. Most of these turn out to be a seroma or something else harmless, and that is exactly why having them checked costs you little.
If it is suspected
How it is investigated and treated
The pathway is well established, and most women are treated with surgery alone.
Draining the fluid and testing it
The swelling is aspirated with a needle and the fluid sent for specific tests. This is the key step, and the laboratory must be told what is being looked for.
Imaging
Ultrasound first to confirm fluid, then MRI or a PET-CT in some cases to see whether anything extends beyond the capsule.
Ask that the request states the suspicion explicitly.Removing the implant and the capsule
The main treatment. Taking out the implant together with the entire capsule is curative for most women whose disease is confined to it.
Further treatment, sometimes
Where disease extends beyond the capsule or has spread, a haematologist becomes involved and systemic treatment may be added. This is the less common situation.
Ask the team
- Has the fluid been tested for this
- Will the whole capsule be removed
- Should a haematologist be involved
Not sure whether this applies to you?
Ask an oncologistTalk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Words you will hear
The vocabulary, in plain language
- BIA-ALCL
- Breast implant associated anaplastic large cell lymphoma. A cancer of immune cells, not of breast tissue.
- Textured implant
- An implant with a roughened surface, designed to reduce movement. Almost all reported cases involve this type.
- Late seroma
- Fluid collecting around an implant long after surgery. Usually harmless, and the presentation that must be tested.
- Capsulectomy
- Removing the scar capsule around the implant. Removing it completely is the main treatment here.
- CD30
- A marker the laboratory tests the fluid for. The request has to ask for it specifically.
- Haematologist
- A specialist in blood and immune system cancers, involved where disease extends beyond the capsule.
Being straight with you
Putting the risk in proportion
This is a rare condition. The great majority of women with textured implants will never develop it, and it should not by itself stop you having a reconstruction. What it should do is make you report sudden swelling rather than waiting.
It can appear many years later
Most cases are diagnosed a good many years after the implant was placed, not in the months afterwards. That long gap is part of why the swelling gets dismissed: by then the surgery feels like ancient history and nobody connects the two. Keep the implant card indefinitely for that reason.
Removing healthy implants is not recommended
If you have textured implants and no symptoms, guidance in most countries does not advise removing them as a precaution. Surgery carries its own risks. Ask your surgeon what applies where you are treated.
The delay usually comes from the patient, not the doctor
Swelling years after an uneventful reconstruction feels like an inconvenience rather than an alarm, so women wait months. That delay is the main thing worth changing, and it is entirely within your control.
Registries exist, and they matter
Several countries now keep registers of which implants are placed in whom, precisely so that patterns like this are picked up rather than missed for years. If you are offered the chance to have your implant recorded on one, it costs you nothing and it is how the next generation of women gets better information.
Outcomes are generally good when caught early
Where the disease is confined to the capsule, removing the implant and the whole capsule treats most women successfully without further treatment. That is why reporting the swelling matters so much more than worrying about the risk.
Commonly believed
What women read about this online
Implants are not considered a cause of ordinary breast cancer. This is a separate, rare condition of the immune system arising in the capsule, strongly linked to textured surfaces. It is not a reason to avoid reconstruction.
Guidance in most countries does not recommend removing implants in women without symptoms, because surgery carries its own risks. Knowing which type you have and reporting swelling promptly is what actually helps.
Usually it is, and that assumption is exactly why diagnosis gets delayed. A late seroma should be drained and the fluid tested specifically for this. Asking whether that test was requested is a fair question.
Where the disease is confined to the capsule, most women are treated successfully by removing the implant and the entire capsule, with no systemic treatment at all. Further treatment is for the less common cases that extend beyond it.
Questions we are asked
Common questions about BIA-ALCL
How do I find out what type of implant I have?
Your implant card, given at the time of surgery, states the manufacturer, type and whether it is textured or smooth. If you no longer have it, your operating hospital holds the record and will tell you. It is worth asking.
Is it breast cancer coming back?
No. It is a cancer of immune cells arising in the scar capsule around the implant, not a recurrence of your breast cancer. It is investigated and treated quite differently, which is why the distinction matters.
How likely is it?
Rare, and the great majority of women with textured implants never develop it. Ask your surgeon for the current estimate for the specific implant type you have, since the figures differ considerably between textures.
Should I have my textured implants swapped?
Not routinely if you have no symptoms, because surgery carries its own risks and guidance in most countries advises against precautionary removal. If you are having surgery anyway for another reason, ask whether a smooth implant is appropriate.
What exactly should I report?
A reconstructed breast that swells noticeably over days or weeks, especially more than a year after surgery. Also a new lump in the breast or armpit, persistent pain, or a skin change over the implant. Most prove harmless.
Will the fluid be tested automatically?
Not always, which is why asking matters. The laboratory needs to be told what is being looked for. It is entirely reasonable to ask whether the sample has been sent with this specifically requested.
Can I still have a reconstruction if I want one?
Yes. This condition is rare and is strongly linked to particular textured surfaces, several of which have been withdrawn. Discuss implant type with your surgeon, and remember that reconstruction using your own tissue avoids implants altogether.
Does it affect follow-up for my breast cancer?
No, your breast cancer follow-up continues as planned. This sits alongside it rather than replacing it. Your other breast still needs its yearly mammogram, which remains the part most likely to be forgotten.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Sources
- National Cancer Institute — Breast implant-associated ALCL
- Cancer Research UK — Breast implants and cancer risk
- Breast Cancer Now — Breast implants and ALCL
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.